Combined effects of valproate and naringin on kidney antioxidative markers and serum parameters of kidney function in C57BL6 mice

Jutrić, David; Đikić, Domagoj; Boroš, Almoš; Odeh, Dyana; Gračan, Romana; Beletić, Anđelo; Jurčević, Irena Landeka

doi:10.2478/aiht-2023-74-3764

Abstract

Valproate is known to disturb the kidney function, and high doses or prolonged intake may cause serum ion imbalance, kidney tubular acidosis, proteinuria, hyperuricosuria, polyuria, polydipsia, and dehydration. The aim of this in vivo study was to see whether naringin would counter the adverse effects of high-dose valproate in C57Bl/6 mice and to which extent. As expected, valproate (150 mg/kg bw a day for 10 days) caused serum hyperkalaemia, more in male than female mice. Naringin reversed (25 mg/kg bw a day for 10 days) the hyperkalaemia and activated antioxidative defence mechanisms (mainly catalase and glutathione), again more efficiently in females. In males naringin combined with valproate was not as effective and even showed some prooxidative effects.

References

Anguissola G, Leu D, Simonetti GD, Simonetti BG, Lava SAG, Milani GP, Bianchetti MG, Scoglio M. Kidney tubular injury induced by valproic acid: systematic literature review. Pediatr Nephrol 2023;38:1725–31. doi: 10.1007/s00467-022-05869-8
Open DOI Search in Google Scholar Back to article
Karatzas A, Paridis D, Kozyrakis D, Tzortzis V, Samarinas M, Dailiana Z, Karachalios T. Fanconi syndrome in the adulthood. The role of early diagnosis and treatment. J Musculoskelet Neuronal Interact 2017;17:303–6. PMCID: PMC5749037
Search in Google Scholar Back to article
Heidari R, Jafari F, Khodaei F, ShiraziYeganeh B, Niknahad H. Mechanism of valproic acid induced Fanconi syndrome involves mitochondrial dysfunction and oxidative stress in rat kidney. Nephrology 2018; 23:351–61. doi: 10.1111/nep.13012
Open DOI Search in Google Scholar Back to article
Ono H. Sodium valproate-induced Fanconi syndrome in two severely disabled patients receiving carnitine supplementation. Clin Exp Nephrol 2019;23:148–9. doi: 10.1007/s10157-018-1581-3
Open DOI Search in Google Scholar Back to article
Gezginci-Oktayoglu S, Turkyilmaz IB, Ercin M, Yanardag R, Bolkent S. Vitamin U has a protective effect on valproic acid-induced renal damage due to its anti-oxidant, anti-inflammatory, and anti-fibrotic properties. Protoplasma 2016;253:127–35. doi: 10.1007/s00709-015-0796-3
Open DOI Search in Google Scholar Back to article
El-Shenawy NS, Hamza RZ. Nephrotoxicity of sodium valproate and protective role of L-cysteine in rats at biochemical and histological levels. J Basic Clin Physiol Pharmacol 2016;27:497–504. doi: 10.1515/jbcpp-2015-0106
Open DOI Search in Google Scholar Back to article
Chaudhary S, Ganjoo P, Raiusddin S, Parvez S. Nephroprotective activities of quercetin with potential relevance to oxidative stress induced by valproic acid. Protoplasma 2015;252:209–17. doi: 10.1007/s00709-014-0670-8
Open DOI Search in Google Scholar Back to article
Koroglu OF, Gunata M, Vardi N, Yildiz A, Ates B, Colak C, Tanriverdi LH, Parlakpinar H. Protective effects of naringin on valproic acid-induced hepatotoxicity in rats. Tissue Cell 2021;72:101526. doi: 10.1016/j.tice.2021.101526
Open DOI Search in Google Scholar Back to article
Jutrić D, Đikić D, Boroš A, Odeh D, Drozdek SD, Gračan R, Dragičević P, Crnić I, Jurčević IL. Effects of naringin and valproate interaction on liver steatosis and dyslipidaemia parameters in male C57BL6 mice. Arh Hig Rada Toksikol 2022;73:71–82. doi: 10.2478/aiht-2022-73-3608
Open DOI Search in Google Scholar Back to article
Stabrauskiene J, Kopustinskiene DM, Lazauskas R, Bernatoniene J. Naringin and naringenin: their mechanisms of action and the potential anticancer activities. Biomedicines 2022;10:1686. doi: 10.3390/biomedicines10071686
Open DOI Search in Google Scholar Back to article
Amini N, Maleki M, Badavi M. Nephroprotective activity of naringin against chemical-induced toxicity and renal ischemia/reperfusion injury: A review. Avicenna J Phytomed 2022;12:357–70. doi: 10.22038/AJP.2022.19620
Open DOI Search in Google Scholar Back to article
Wang R, Wu G, Dai T, Lang Y, Chi Z, Yang S, Dong D. Naringin attenuates renal interstitial fibrosis by regulating the TGF-β/Smad signaling pathway and inflammation. Exp Ther Med 2021;21:66. doi: 10.3892/etm.2020.9498
Open DOI Search in Google Scholar Back to article
Elsawy H, Alzahrani AM, Alfwuaires M, Abdel-Moneim AM, Khalil M. Nephroprotective effect of naringin in methotrexate induced renal toxicity in male rats. Biomed Pharmacother 2021;143:112180. doi: 10.1016/j.biopha.2021.112180
Open DOI Search in Google Scholar Back to article
Committee for the Update of the Guide for the Care and Use of Laboratory Animals. Guide for the care and use of laboratory animals. ^8th ed. Washington (DC): National Academies Press; 2011.
Search in Google Scholar Back to article
Landeka Jurčević I, Dora M, Guberović I, Petras M, Rimac S, Brnčić, Đikić D. Polyphenols from wine lees as a novel functional bioactive compound in the protection against oxidative stress and hyperlipidaemia. Food Technol Biotechnol 2017;55:109–16. doi: 10.17113/ftb.55.01.17.4894
Open DOI Search in Google Scholar Back to article
Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem 1951;193:265–75. doi: 10.1016/S0021-9258(19)52451-6
Open DOI Search in Google Scholar Back to article
Flohé L, Ötting F. Superoxide dismutase assays. Meth Enzymol 1984;105:93–104. doi: 10.1016/s0076-6879(84)05013-8
Open DOI Search in Google Scholar Back to article
Aebi H. Catalase in vitro. Meth Enzymol 1984;105:121–6. doi: 10.1016/s0076-6879(84)05016-3
Open DOI Search in Google Scholar Back to article
Eyer P, Worek F, Kiderlen D, Sinko G, Stuglin A, Simeon-Rudolf V, Reiner E. Molar absorption coefficients for the reduced Ellman reagent: reassessment. Anal Biochem 2003;312:224–7. doi: 10.1016/s0003-2697(02)00506-7
Open DOI Search in Google Scholar Back to article
Pirahanchi Y, Jessu R, Aeddula NR. Physiology, sodium potassium pump. Treasure Island (FL). StatPearls Publishing; 2022.
Search in Google Scholar Back to article
White KE, Gesek FA, Nesbitt T, Drezner MK, Friedman PA. Molecular dissection of Ca²⁺ efflux in immortalized proximal tubule cells. J Gen Physiol 1997;109:217–28. doi: 10.1085/jgp.109.2.217
Open DOI Search in Google Scholar Back to article
Curry JN, Yu ASL. Paracellular calcium transport in the proximal tubule and the formation of kidney stones. Am J Physiol Renal Physiol 2019;316:966–9. doi: 10.1152/ajprenal.00519.2018
Open DOI Search in Google Scholar Back to article
Gumz ML, Lynch IJ, Greenlee MM, Cain BD, Wingo CS. The renal H+-K+-ATPases: physiology, regulation, and structure. Am J Physiol Renal Physiol 2010;298:12–21. doi: 10.1152/ajprenal.90723.2008
Open DOI Search in Google Scholar Back to article
Đikić D, Jutrić D, Dominko K. The dual nature of the antiepileptic drug valproic acid, with possible beneficial effects in Alzheimer’s disease. SEEMEDJ 2017;1:74–89. doi: 10.26332/seemedj.v1i1.26
Open DOI Search in Google Scholar Back to article
Monostory K, Nagy A, Tóth K, Bűdi T, Kiss Á, Déri M, Csukly G. Relevance of CYP2C9 function in valproate therapy. Curr Neuropharmacol 2019;17:99–106. doi: 10.2174/1570159X15666171109143654
Open DOI Search in Google Scholar Back to article
Knights KM, Rowland A, Miners JO. Renal drug metabolism in humans: the potential for drug-endobiotic interactions involving cytochrome P450 (CYP) and UDP-glucuronosyltransferase (UGT). Br J Clin Pharmacol 2013;76:587–602. doi: 10.1111/bcp.12086
Open DOI Search in Google Scholar Back to article
Ding S, Qiu H, Huang J, Chen R, Zhang J, Huang B, Zou X, Cheng O, Jiang Q. Activation of 20-HETE/PPARs involved in reno-therapeutic effect of naringenin on diabetic nephropathy. Chem Biol Interact 2019;307:116–24. doi: 10.1016/j.cbi.2019.05.004
Open DOI Search in Google Scholar Back to article
Oyagbemi AA, Omobowale TO, Adejumobi OA, Owolabi AM, Ogunpolu BS, Falayi OO, Hassan FO, Ogunmiluyi IO, Asenuga ER, Ola-Davies OE, Soetan KO, Saba AB, Adedapo AA, Nkadimeng SM, McGaw LJ, Oguntibeju OO, Yakubu MA. Antihypertensive power of Naringenin is mediated via attenuation of mineralocorticoid receptor (MCR)/ angiotensin converting enzyme (ACE)/kidney injury molecule (Kim-1) signaling pathway. Eur J Pharmacol 2020;880:173142. doi: 10.1016/j.ejphar.2020.173142
Open DOI Search in Google Scholar Back to article
Amudha K, Pari L. Beneficial role of naringin, a flavanoid on nickel induced nephrotoxicity in rats. Chem Biol Interact 2011;193:57–64. doi: 10.1016/j.cbi.2011.05.003
Open DOI Search in Google Scholar Back to article
Caglayan C, Temel Y, Kandemir FM, Yildirim S, Kucukler S. Naringin protects against cyclophosphamide-induced hepatotoxicity and nephrotoxicity through modulation of oxidative stress, inflammation, apoptosis, autophagy, and DNA damage. Environ Sci Pollut Res Int 2018;25:20968–84. doi: 10.1007/s11356-018-2242-5
Open DOI Search in Google Scholar Back to article
Singh D, Chander V, Chopra K. Protective effect of naringin, a bioflavonoid on glycerol-induced acute renal failure in rat kidney. Toxicology 2004;201:143–51. doi: 10.1016/j.tox.2004.04.018
Open DOI Search in Google Scholar Back to article
Amini N, Sarkaki A, Dianat M, Mard SA, Ahangarpour A, Badavi M. The renoprotective effects of naringin and trimetazidine on renal ischemia/ reperfusion injury in rats through inhibition of apoptosis and downregulation of micoRNA-10a. Biomed Pharmacother 2019;112:108568. doi: 10.1016/j.biopha.2019.01.029
Open DOI Search in Google Scholar Back to article
Galati G, Chan T, Wu B, O’Brien PJ. Glutathione-dependent generation of reactive oxygen species by the peroxidase-catalyzed redoxcycling of flavonoids. Chem Res Toxicol 1999;12:521–525. doi: 10.1021/tx980271b
Open DOI Search in Google Scholar Back to article

Combined effects of valproate and naringin on kidney antioxidative markers and serum parameters of kidney function in C57BL6 mice

Abstract

Paradigm

My account